Navigation Links
Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
Date:11/13/2009

hen is approved in approximately 80 countries, including major markets in Europe, where it is the market leader among all injectable analgesics. Approximately 90 million vials of IV acetaminophen were sold in Europe in 2008 representing an increase of approximately 13% over 2007.

The NDA for IV acetaminophen includes data from one pivotal clinical trial for the treatment of acute pain in patients following orthopedic surgery and one pivotal clinical trial for the treatment of fever. The NDA is further supported by data from a total of nine placebo-controlled clinical trials, four active-controlled clinical trials, and seven other safety or pharmacokinetic clinical trials. The submission includes safety data from over 1,400 patients who received IV acetaminophen in clinical trials, including 350 pediatric patients, from premature neonates to adolescents, and data from safety reports that collectively represent more than 53 million patient exposures to IV acetaminophen in countries outside the United States.

Conference Call and Webcast on November 13, 2009 at 5:30 a.m. Pacific Time (8:30 a.m. Eastern Time)

Cadence management will host a conference call on November 13, 2009 at 5:30 a.m. Pacific Time (8:30 a.m. Eastern Time) and interested investors may participate in the conference call by dialing 800-967-7137 (domestic) or 719-785-9446 (international). To access the webcast, please visit the company's website at www.cadencepharm.com and go to the Investor Relations page. A replay of the webcast will be available approximately two hours after the call and remain available on the company's website until the next quarterly financial results call.

About Cadence

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital s
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
2. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
3. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
4. Cadence Pharmaceuticals Updates Omigard(TM) Clinical Timeline
5. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
6. Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
7. Cadence Pharmaceuticals to Webcast October 7th Analyst Day
8. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the BIOCOM Investor Conference in San Diego on October 27, 2009
9. Cadence Pharmaceuticals CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009
10. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... May 05, 2015 Research and Markets ... of the "Chromatography (Instruments and Reagents) Global ... their offering. Chromatography is an analytical ... component of a complex mixture by differential movement ... the scientists have considered chromatography as an esoteric ...
(Date:5/6/2015)...   CEFALY Technology , the creators of the ... for use prior to the onset of migraine pain, ... at the EUROHEADPAIN - Midterm Meeting at the International ... , from May 14-17, 2015. On May ... major European research project focused on migraines, CEFALY ...
(Date:5/6/2015)... 2015 Advanced wound care - assess products, ... the future hold for the advanced wound care ... you potential revenues to 2025, assessing data, trends, opportunities ... report provides 115 tables, charts, and graphs covering 12 ... the industry and the future market prospects. You will ...
Breaking Medicine Technology:Global Chromatography (Instruments and Reagents) Market 2015 - Forecasts to 2019 2CEFALY to Present Breakthrough Data in Migraine Treatment at International Headache Society Congress 2Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 2Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 3Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 4Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 5Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 6
... PharmaSecure Inc, a pioneer in pharmaceutical authentication technology, ... Schmidt,s Innovation Endeavors, Gray Ghost Ventures, Healthtech Capital and ... to create new applications to respond to the Government ... next year. This year, the Directorate General ...
... and PORTOLA VALLEY, Calif., Oct. 24, 2011 Goodwin ... collaboration for the process development and cGMP manufacturing of ... Phase I and Phase II clinical trials. ... or removal of the prostate," noted David Benaron, CEO ...
Cached Medicine Technology:PharmaSecure, an Innovator in Pharmaceutical Serialization, Closes $3.9M Investment by Eric Schmidt's Innovation Endeavors, Gray Ghost Ventures, Healthtech Capital and the TEEC Angel Fund 2Goodwin Biotechnology Announces a Collaboration with Spectros Corporation 2
(Date:5/6/2015)... Chesapeake Regional Medical Center is the ... acquire Intuitive Surgical, Inc.’s latest model of the ... enhanced surgical technique capabilities, which can be used ... spectrum of specialties. Its advancements allow patients less ... times. , “As the only independent, community-based hospital ...
(Date:5/6/2015)... TX (PRWEB) May 06, 2015 The ... Issue 1 of Patient Experience Journal (PXJ), an ... proven practices around understanding and improving patient experience. The ... the patient experience conversation globally, helps align the voices ... impact. , Published in association with The Beryl ...
(Date:5/6/2015)... Denver, Colorado (PRWEB) May 06, 2015 ... own success? , Next month the Centennial State will ... legal, recreational cannabis sales to adults. And while Colorado’s ... rapid growth during that time, it’s also facing some ... the state are currently facing shortages, especially in the ...
(Date:5/6/2015)... vcfo, a specialized consulting firm that ... support to optimize business performance and productivity, announced the ... Michael Scheaffer. Both Lynch and Scheaffer have more than ... , “We are delighted to add Jack and Mike ... their background in financial management and leadership, Mike and ...
(Date:5/6/2015)... Anitoa Systems, (“Anitoa”), a Palo Alto startup established ... has successfully demonstrated a handheld real time quantitative-polymerase-chain-reaction system ... handheld qPCR is shown to be capable of detecting ... B, C, and E. Coli. This qPCR system has ... over 9 orders of magnitude dynamic range. A ...
Breaking Medicine News(10 mins):Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 3Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 3Health News:vcfo Adds Two Senior Executives to Growing Team 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 3
... Today,s ubiquitous MP3 players permit users to listen to crystal-clear ... marked improvement on the days of the Walkman. But according ... personal listening devices into a serious health hazard, with teenagers ... four teens is in danger of early hearing loss as ...
... Allergists, pulmonologists and general practitioners can learn the approaches ... and immune diseases at the 34th Annual Pulmonary & ... Jewish Health. The program, co-chaired by National Jewish professors ... MD, offers an opportunity to interact with the world,s ...
... single class of proteins and now scientists have identified ... those proteins critical to our health. A protein known ... from a team led by Gregory Tall, Ph.D., assistant professor ... Center. The work was published recently in Science Signaling ...
... -- While the holidays tend to translate into restaurant meals ... at home, eating out doesn,t have to be unhealthy, an ... Americans from consuming hundreds of extra calories. "The average ... meals outside of the home and fast-food restaurants are abundant," ...
... WASHINGTONDecember 27, 2011Research!America,s new national voter education initiative, ... and Republican Presidential candidate Newt Gingrich on important ... highlights: both Obama and Gingrich agree that ... part of the solution to rising health care ...
... Maryland, December, 27, 2011 Neuralstem, Inc. (NYSE Amex: CUR) ... and Drug Administration to advance to Phase Ib in ... compound, NSI-189, for the treatment of major depressive disorder ... of the drug in depressed patients. NSI-189 is a ...
Cached Medicine News:Health News:Turn down the iPod to save your hearing 2Health News:Scientists fixate on Ric-8 to understand trafficking of popular drug receptor targets 2Health News:Eating Out Doesn't Have to Mean Excess Calories 2Health News:President Obama and leading GOP presidential candidate support health research 2Health News:President Obama and leading GOP presidential candidate support health research 3Health News:Neuralstem's NSI-189 trial in major depressive disorder receives FDA approval to advance to Phase Ib 2Health News:Neuralstem's NSI-189 trial in major depressive disorder receives FDA approval to advance to Phase Ib 3
... duet Signature Series multipurpose gamma ... FDG imaging applications. The system uniquely combines ... the features and flexibility of modern day ... unit.,The e.cam duet maximizes camera ...
In Stainless steel. Available in 1.5, 2.0,3.0 & 3.5 MM...
... AXIOM Artis FA is ... C-arm system whose flexible ... for vascular and non-vascular ... provides complete ergonomic system ...
.60 x 22mm, angled 60, .33mm end port [Simcoe]...
Medicine Products: